A+C in Metastatic Lung Adenocarcinoma Cancer

Clinical trial NCT02946359 · UNKNOWN

Trial details

NCT number: NCT02946359
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Adenocarcinoma Metastatic

Start date: 2016-07-01
Primary completion: 2017-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.